Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence (pages 479–490)
Jeannie Shen, Kelly K. Hunt, Nadeem Q. Mirza, Thomas A. Buchholz, Gildy V. Babiera, Henry M. Kuerer, Isabelle Bedrosian, Merrick I. Ross, Frederick C. Ames, Barry W. Feig, S. Eva Singletary, Massimo Cristofanilli and Funda Meric-Bernstam
Article first published online: 20 JUN 2005 | DOI: 10.1002/cncr.21224
The management of patients with ipsilateral breast tumor recurrences (IBTR) remains controversial. In this study, the authors found that initial lymph node-positive disease and skin involvement or lymphovascular invasion at IBTR were independent predictors of poor outcome after IBTR.